FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/12/2022
Back to search
Official data from USPTO
LABCEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LABCEUTICS
ST13
US500000079297338Class
9, 42
Filing
79297338
Registration
6604418
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/12/2022
Trademark type
Word
Nice classes
9, 42
Filing date
09/10/2020
Registration date
01/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2022
Last transaction
01/04/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
84
Owner location
GB
Examiner
LAWRENCE, SUE
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Diaceutics Plc
Representatives
MARGARET M. POWERS SHAY GLENN LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software used in respect of medicine and pharmaceutical research and development services for data managementdata analysisdata manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data; downloadable computer software for use in relation to business networking and content management; downloadable computer software applications delivered to any computing device including desktoplaptop and tablet computers as well as mobile devices for data management and visualisationfor generating reportscharts and dashboards
Class 42
Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; medical research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing servicescomputer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of medical diagnostic preparations; design and development of computer databases; design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis servicesdata analysis for medicine and pharmaceutical testingresearch and development purposes; software as a service (SaaS) services featuring non-downloadable software for data managementdata analysisdata manipulationmedicine and pharmaceutical testingresearch and development services; software as a service (SaaS) services featuring non-downloadable software enabling communication between laboratory networks and diagnostic and pharmaceutical companies; software as a service (SaaS) services featuring non-downloadable software for data management and visualisationincluding generating reportscharts and dashboards; platform as a service (PaaS) services featuring non-downloadable software platforms for data managementdata analysisdata manipulationmedicine and pharmaceutical testingresearch and development services; platform as a service (PaaS) services featuring non-downloadable software platforms enabling communication between laboratory networks and diagnostic and pharmaceutical companies; platform as a service (PaaS) services featuring non-downloadable software platforms for data management and visualisationincluding generating reportscharts and dashboards; informationadvice and consultancy in relation to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
22 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/17/2022
FIMP
FINAL DISPOSITION PROCESSED
06/17/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/19/2021
PUBO
PUBLISHED FOR OPPOSITION
10/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/29/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/27/2021
RFNT
REFUSAL PROCESSED BY IB
03/01/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/06/2021
RFRR
REFUSAL PROCESSED BY MPU
02/06/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/23/2021
CNRT
NON-FINAL ACTION WRITTEN
01/22/2021
DOCK
ASSIGNED TO EXAMINER
01/21/2021
MAFR
APPLICATION FILING RECEIPT MAILED
11/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/05/2020
Continuous trademark protection
Get notified about every new filing that threatens LABCEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.